Elimination of Rubella and Congenital Rubella Syndrome in the Americas
Open Access
- 1 September 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 204 (suppl_2) , S571-S578
- https://doi.org/10.1093/infdis/jir472
Abstract
In 2003, the Pan American Health Organization (PAHO) adopted a resolution calling for rubella and congenital rubella syndrome (CRS) elimination in the Americas by the year 2010. To accomplish this goal, PAHO advanced a rubella and CRS elimination strategy including introduction of rubella-containing vaccines into routine vaccination programs accompanied by high immunization coverage, interruption of rubella transmission through mass vaccination of adolescents and adults, and strengthened surveillance for rubella and CRS. The rubella elimination strategies were aligned with the successful measles elimination strategies. By the end of 2009, all countries routinely vaccinated children against rubella, an estimated 450 million people had been vaccinated against measles and rubella in supplementary immunization activities, and rubella transmission had been interrupted. This article describes how the region eliminated rubella and CRS.Keywords
This publication has 6 references indexed in Scilit:
- Feasibility of global measles eradication after interruption of transmission in the AmericasExpert Review of Vaccines, 2008
- Rubella Elimination and Improving Health Care for Women1Emerging Infectious Diseases, 2004
- New Horizons in the Control of Rubella and Prevention of Congenital Rubella Syndrome in the AmericasThe Journal of Infectious Diseases, 2003
- Control acelerado de la rubéola y prevención del síndrome de rubéola congénita en las AméricasRevista Panamericana de Salud Pública, 2002
- Modelling the incidence of congenital rubella syndrome in developing countriesInternational Journal of Epidemiology, 1999